Stream Biomedical
Houston, US · Delaware corporation · 1 known investors
Preclinical biotech developing first-in-class treatments for serious neurodegenerative disorders such as stroke, using its engineered perlecan domain V.
Biotech
Founders & leadership
CG
Chris GarabedianDirector
WS
William SchwietermanExecutive Officer, Director
FC
Fred CalloriDirector
AD
Amanda De La GarzaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$21.5MraisedJan 2022 · 11 investors · PharmaceuticalsRule 506(b)
▶$21.5MraisedJan 2022 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chris GarabedianDirector
- Amanda De La GarzaDirector
- William SchwietermanExecutive Officer, Director
- Fred CalloriDirector
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- Minimum investment
- $50K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.